Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq.

Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq.

Since December 2019, the World Health Organization (WHO) has encouraged National Tuberculosis Programs to deprioritize the use of injectable-containing regimens and roll-out all-oral bedaquiline-containing regimens for rifampicin-resistant tuberculosis (RR-TB) treatment. Consequently, Iraq gradually...

Full description

Bibliographic Details
Main Authors: Hiwot Melak Tesfahun, Layth Al-Salihi, Nadia Abdulkareem Al-Ani, Ahmed Asmer Mankhi, Ammar Mohammed, Chenery Ann E Lim, Riadh Abdulameer Al-Hilfi, Christelle G Jouego, Tom Decroo, Krystel Moussally, Gabriella Ferlazzo, Petros Isaakidis
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0296952&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0296952&type=printable

Similar Items